SC asks Ramdev, Balkrishna to appear personally in misleading ads case

The summon followed Patanjali Ayurved and Acharya Balkrishna's failure to respond to a contempt notice of the top court

Patanjali, Baba ramdev
Bhavini Mishra
3 min read Last Updated : Mar 19 2024 | 9:13 PM IST

Don't want to miss the best from Business Standard?

The Supreme Court on Tuesday summoned Patanjali Ayurved’s Cofounder Baba Ramdev and Managing Director Acharya Balkrishna to appear before it for failing to reply to the court’s contempt notice. This notice was issued against them and the company in relation to a case concerning misleading advertisements.

The court, on February 27, issued a contempt notice to Patanjali Ayurved and Acharya Balkrishna for flouting its previous orders by continuing to make false and misleading claims regarding the efficacy of their products in curing diseases.

Both the company and Balakrishna had been asked to reply in three weeks why action against them should not be taken.

“How can you be in teeth of our orders? We had our hands tied earlier but not now,” a bench of Justices Hima Kohli and Ahsanuddin Amanullah said.

ALSO READ: What is the Magic Remedies Act under which Patanjali is facing scrutiny

Senior advocate Mukul Rohatgi, appearing for Patanjali Ayurved, took objection to this and said, “How does Ramdev come into the picture? Violation of law is not contempt of court. What is being relied on in open court has to be recorded in the order.”

However, the court did not entertain Rohatgi’s argument and summoned Ramdev and Acharya to be present in court. It also asked the duo to file a reply to the contempt notice issued last month. Patanjali Ayurved is the parent company of Patanjali Foods.

The court also said the duo were in violation of Sections 3 and 4 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.


The Bench of Justices Hima Kohli and Ahsanuddin Amanullah had, in the last hearing, temporarily restrained Patanjali Ayurved from advertising or branding its products which are meant to address the diseases/disorders specified in the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954. The court had warned Patanjali from making any statement against any system of medicine.

The apex court also asked the Centre to file an affidavit on steps it has taken under the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 in respect of the advertisements of Patanjali.

“The entire country is taken for a ride. You wait for two years when the Act says this (misleading advertisements) is prohibited,” Justice Ahsanuddin Amanullah told Additional Solicitor General KM Nataraj. While Nataraj agreed that misleading advertisements cannot be accepted, he said that it is up to the States to take action under the Act.

The court was hearing a petition filed by the Indian Medical Association (IMA) alleging that the ‘yoga guru and his company’ had started a ‘smear campaign’ against the Covid-19 vaccination drive and modern medicine.

When the case was taken up in the morning, Justice Amanullah came down heavily on Patanjali for yet another advertisement that contained misleading claims.

“You had the courage and guts to come up with this advertisement after the order of this Court! And then you come up with this advertisement. Permanent relief, what do you mean by permanent relief? Is it a cure? We are going to pass a very, very strict order. You are tempting the Court,” the judge had said.



“You had the courage and guts to come up with this advertisement after the order of this Court! …We are going to pass a very, very strict order” – Justice Ahsanuddin Amanullah, Supreme Court of India  






*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Supreme CourtPatanjali AyurvedPatanjali Ayurved RamdevBaba Ramdev

First Published: Mar 19 2024 | 8:45 PM IST

Next Story